The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.68 in the prior trading day, CareMax Inc (NASDAQ: CMAX) closed at $0.87, down -48.21%. In other words, the price has decreased by -$48.21 from its previous closing price. On the day, 0.83 million shares were traded. CMAX stock price reached its highest trading level at $0.988 during the session, while it also had its lowest trading level at $0.695.
Ratios:
Our goal is to gain a better understanding of CMAX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.23 and its Current Ratio is at 0.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on February 26, 2024, Downgraded its rating to Hold and sets its target price to $7.50 from $1.50 previously.
On November 17, 2023, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $5 to $1.
Piper Sandler Downgraded its Overweight to Neutral on November 10, 2023, whereas the target price for the stock was revised from $3 to $2.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMAX now has a Market Capitalization of 3319024 and an Enterprise Value of 503186144. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.00. Its current Enterprise Value per Revenue stands at 0.641 whereas that against EBITDA is -4.645.
Stock Price History:
The Beta on a monthly basis for CMAX is 0.65, which has changed by -0.92134833 over the last 52 weeks, in comparison to a change of 0.2936039 over the same period for the S&P500. Over the past 52 weeks, CMAX has reached a high of $32.10, while it has fallen to a 52-week low of $1.18. The 50-Day Moving Average of the stock is -52.77%, while the 200-Day Moving Average is calculated to be -75.38%.
Shares Statistics:
The stock has traded on average 306.18K shares per day over the past 3-months and 125410 shares per day over the last 10 days, according to various share statistics. A total of 3.74M shares are outstanding, with a floating share count of 2.36M. Insiders hold about 38.07% of the company’s shares, while institutions hold 25.59% stake in the company. Shares short for CMAX as of 1730332800 were 463584 with a Short Ratio of 1.51, compared to 1727654400 on 162993. Therefore, it implies a Short% of Shares Outstanding of 463584 and a Short% of Float of 19.08.
Earnings Estimates
A comprehensive evaluation of CareMax Inc (CMAX) is underway, with the input of 1.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$3.58, with high estimates of -$3.58 and low estimates of -$3.58.
Analysts are recommending an EPS of between -$20.83 and -$20.83 for the fiscal current year, implying an average EPS of -$20.83. EPS for the following year is -$15.82, with 1.0 analysts recommending between -$15.82 and -$15.82.
Revenue Estimates
1 analysts predict $172.4M in revenue for the current quarter. It ranges from a high estimate of $172.4M to a low estimate of $172.4M. As of the current estimate, CareMax Inc’s year-ago sales were $201.84MFor the next quarter, 1 analysts are estimating revenue of $169.12M. There is a high estimate of $169.12M for the next quarter, whereas the lowest estimate is $169.12M.
A total of 1 analysts have provided revenue estimates for CMAX’s current fiscal year. The highest revenue estimate was $772.4M, while the lowest revenue estimate was $772.4M, resulting in an average revenue estimate of $772.4M. In the same quarter a year ago, actual revenue was $751.1MBased on 1 analysts’ estimates, the company’s revenue will be $1.24B in the next fiscal year. The high estimate is $1.24B and the low estimate is $1.24B.
